Abo, Anjelyn B.

HRN: 18-53-21  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/01/2026
CO-AMOXICLAV 625MG (TAB)
08/01/2026
08/08/2026
PO
625mg
BID X 7 Days
S/P NSVD With RMLE; Thinly MSAF
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: